Related Experiment Video
Updated: Aug 25, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
Novel pH-sensitive paramagnetic liposomes with improved MR properties
Knut-Egil Løkling1, Roald Skurtveit, Atle Bjørnerud
1Department of Medicinal Chemistry, School of Pharmacy, University of Oslo, Oslo, Norway. knut-egil.loking@amersham.com
Abstract:
The use of paramagnetic pH-sensitive liposomes was recently suggested as a new approach for monitoring pathologic changes in pH by MRI. Such liposomes must be stable in blood and selectively release the encapsulated paramagnetic agent when exposed to lower pH in the target tissue. In the present study, different liposomal systems were formulated and characterized by relaxometry, cryo-transmission electron microscopy (cryo-TEM), and MRI. The pH-sensitive system dipalmitoylphosphatidylethanolamine/palmitic acid (DPPE/PA) liposomal GdDTPA-BMA, which was previously shown to be unstable in blood, was modified to improve its stability. The incorporation of cholesterol into the DPPE/PA liposomes significantly increased their stability in blood, but the pH sensitivity was diminished. Polyethylene glycol (PEG)-modified DPPE/PA liposomes were pH-insensitive in buffer, and unstable in blood. However, exchanging PA with the double-chained amphiphile dipalmitoylglycerosuccinate (DPSG) yielded liposomes with improved properties. DPPE/DPSG liposomal GdDTPA-BMA was stable in blood at physiological pH, and displayed a marked pH sensitivity. The pH sensitivity was not diminished after preincubation in blood, contrary to what has been reported for analogues containing unsaturated lipids. The potential of this system for monitoring pH was demonstrated in an in vitro MRI phantom study.
Insights
New pH-sensitive liposomes offer improved stability for MRI monitoring of pathologic pH changes. The dipalmitoylglycerosuccinate (DPSG)-based system demonstrates stability in blood and selective pH sensitivity, showing promise for in vitro diagnostic applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Magnetic Resonance Imaging
Background:
- Paramagnetic pH-sensitive liposomes are a novel approach for MRI-based monitoring of pathological pH variations.
- Essential liposome characteristics include blood stability and selective release of encapsulated agents at lower tissue pH.
Purpose of the Study:
- To formulate and characterize novel liposomal systems for pH monitoring using MRI.
- To enhance the stability of existing pH-sensitive liposomes in blood while maintaining pH responsiveness.
Main Methods:
- Liposomal systems were formulated using dipalmitoylphosphatidylethanolamine (DPPE) with different amphiphiles (palmitic acid (PA), dipalmitoylglycerosuccinate (DPSG)).
- Characterization involved relaxometry, cryo-transmission electron microscopy (cryo-TEM), and MRI.
- Stability was assessed in blood, and pH sensitivity was evaluated in buffer and in vitro MRI phantom studies.
Main Results:
- Cholesterol incorporation into DPPE/PA liposomes improved blood stability but reduced pH sensitivity.
- Polyethylene glycol (PEG)-modified DPPE/PA liposomes were pH-insensitive and unstable in blood.
- DPPE/DPSG liposomal GdDTPA-BMA exhibited stability in blood at physiological pH and marked pH sensitivity, with retained sensitivity after blood preincubation.
Conclusions:
- DPPE/DPSG liposomal GdDTPA-BMA represents an improved system for pH-sensitive MRI contrast agents.
- This formulation demonstrates superior stability and pH responsiveness compared to previous systems.
- The study validates the potential of DPPE/DPSG liposomes for in vitro pH monitoring applications via MRI.
More Related Videos
09:38Fabrication Procedures and Birefringence Measurements for Designing Magnetically Responsive Lanthanide Ion Chelating Phospholipid Assemblies
Published on: January 3, 2018
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025